Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
Authors:
- Torgun WæhreTWTorgun Wæhre
- Jan K DamåsJDJan K Damås
- Lars GullestadLGLars Gullestad
- Are M HolmAHAre M Holm
- Terje R PedersenTPTerje R Pedersen
- Kjell E ArnesenKAKjell E Arnesen
- Harald TorsvikHTHarald Torsvik
- Stig S FrølandSFStig S Frøland
- Anne G SembASAnne G Semb
- P.ål AukrustPAP.ål Aukrust
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Stromal Cell–Derived Factor-1α in Unstable AnginaCirculation, 2002
- Statin Prevents Tissue Factor Expression in Human Endothelial CellsCirculation, 2002
- HMG-CoA Reductase Inhibitor Modulates Monocyte–Endothelial Cell Interaction Under Physiological Flow Conditions In VitroArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Human Vascular Smooth Muscle Cells Possess Functional CCR5Journal of Biological Chemistry, 2000
- Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejectionJournal of Clinical Investigation, 2000
- Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cellsAtherosclerosis, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in CultureCirculation Research, 1998
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Procoagulant and profibrinolytic activities of cryopreserved human monocytesThrombosis Research, 1994